Alora Pharmaceuticals, LLC, Announces Corporate Office Expansion

May 29, 2018

Alora Pharmaceuticals, LLC, parent company of Avion Pharmaceuticals, LLC, and Acella Pharmaceuticals, LLC, announced the relocation of the corporate headquarters of its two companies to a new 58,000 sq. ft. facility at 1880 McFarland Parkway in Alpharetta, Georgia. Both companies completed the move in late February. The new headquarters will provide increased office space, climate-controlled… Learn More

Avion and Acella Pharmaceuticals Provide Statement Related to Avondale Drug Pricing News

December 13, 2017

Avion pharmaceuticals, LLC, and their partner company, Acella Pharmaceuticals recently responded to the recent news surrounding the Avondale Pharmaceuticals product Niacor, a prescription version of niacin. Avion and Acella were made aware of the recent 800 percent price increase for Avondale’s version of niacin, going from $32.46 to $295 per 100 pills. Avion and Acella… Learn More

Acella Pharmaceuticals Signs Product Development Agreement with Catalent To Bring Opioid-Abuse Deter

August 10, 2017

Acella Pharmaceuticals, LLC, a leading U.S. manufacturer of specialty pharmaceuticals across several therapeutic categories, today announced an exclusive, multi-year, multi-product development and licensing partnership with Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, to develop, manufacture, and commercialize a new portfolio of… Learn More

Acella Pharmaceuticals, llc, Announces Approval of Generic to Vituz® Oral Solution

July 27, 2017

Acella Pharmaceuticals, LLC, a leading U.S. developer of specialty pharmaceuticals across several therapeutic categories, recently announced the Food and Drug Administration’s approval of the Company’s abbreviated new drug application (ANDA) for a Hydrocodone Bitartrate and Chlorpheniramine Maleate Oral Solution 5 mg/4 mg per 5 mL as a bioequivalent product to VITUZ® Oral Solution. This approval… Learn More

Acella Pharmaceuticals, llc, Announces Approval of a Generic Bromfed Antihistamine/Decongestant

October 28, 2016

Acella Pharmaceuticals, LLC, a specialty pharmaceutical company, recently secured approval for a sugar-free bioequivalent to the antihistamine/decongestant Bromfed DM® Cough Syrup (brompheniramine maleate, pseudoephedrine hydrochloride, and dextromethorphan hydrobromide syrup, 2mg/30mg/10mg per 5mL).* This combination of pharmaceutical ingredients is used to temporarily relieve the symptoms caused by the common cold, flu, allergies, and other breathing illnesses…. Learn More